Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma

• Verena Sailer ,

  Contributed equally to this work with: Verena Sailer, Heidrun Gevensleben

  Affiliations Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, United States of America, Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, New York, United States of America

  ⨯
• Heidrun Gevensleben ,

  Contributed equally to this work with: Verena Sailer, Heidrun Gevensleben

  Affiliation Institute of Pathology, University Hospital of Bonn, Bonn, Germany

  ⨯
• Joern Dietrich,

  Affiliation Department of Otolaryngology, Head and Neck Surgery, University Hospital Bonn, Bonn, Germany

  ⨯
• Diane Goltz,

  Affiliation Institute of Pathology, University Hospital of Cologne, Cologne, Germany

  ⨯
• Glen Kristiansen,

  Affiliation Institute of Pathology, University Hospital of Bonn, Bonn, Germany

  ⨯
• Friedrich Bootz,

  Affiliation Department of Otolaryngology, Head and Neck Surgery, University Hospital Bonn, Bonn, Germany

  ⨯
• Dimo Dietrich

  * E-mail: dimo.dietrich@gmail.com

  Affiliation Department of Otolaryngology, Head and Neck Surgery, University Hospital Bonn, Bonn, Germany

  http://orcid.org/0000-0001-9794-7927

  ⨯